Ocugen Inc. to Present at Chardan's Annual Genetic Medicines Conference Panel on In Vivo Gene Therapy
Reuters
Oct 02
<a href="https://laohu8.com/S/OCGN">Ocugen</a> Inc. to Present at Chardan's Annual Genetic Medicines Conference Panel on In Vivo Gene Therapy
Ocugen Inc., a biotechnology leader in gene therapies for blindness diseases, will present a company update at the Cell & Gene Meeting on the Mesa on Monday, October 6, 2025. The company's executive leadership will also participate in upcoming industry and investor conferences, sharing progress towards their goal of three BLAs in the next three years.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9539095-en) on October 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.